AN INNOVATIVE PREP RESEARCH STUDY FOR WOMEN

HPTN 084 (LIFE) is a research study that compares the effectiveness of injections and oral tablets as pre-exposure prophylaxis (PrEP) to prevent HIV in women.

HPTN 084 will enroll participants in 20 sites in 7 countries in sub-Saharan Africa: Botswana, Eswatini, Kenya, Malawi, South Africa, Uganda and Zimbabwe.

See site contact information here.

The HPTN

HPTN 084 is a study that is part of the NIH-DAIDS-funded HIV Prevention Trials Network (HPTN). Learn more under Additional Information.